Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Investments: 2013-2016

  • Niagen Bioscience's Long-Term Investments was N/A to $20,318 in Q4 2016 from the same period last year, while for Dec 2016 it was $20,318, marking a year-over-year change of. This contributed to the annual value of $20,318 for FY2016, which is N/A change from last year.
  • According to the latest figures from Q4 2016, Niagen Bioscience's Long-Term Investments is $20,318, which was down 0.00% from $20,318 recorded in Q4 2016.
  • Niagen Bioscience's Long-Term Investments' 5-year high stood at $2.7 million during Q1 2013, with a 5-year trough of $20,318 in Q4 2016.
  • Its 1-year average for Long-Term Investments is $20,318, with a median of $20,318 in 2016.